Anvendelse av NF-KappaB-aktiveringsinhibitor for fremstilling av et medikament for behandling av infarkter.

摘要

This invention is directed to treating ischemia by administering proteasome inhibitors, ubiquitin pathway inhibitors, agents that interfere with the activation of NF-kappaB via the ubiquitin proteasome pathway, or mixtures thereof.